Japanese cruiser Tama
Japanese cruiser Tama was a light cruiser of the Imperial Japanese Navy (IJN), which served during World War II. Tama was part of the Kuma-class of light cruisers, which were designed and built in the early 1920s as part of the IJN's expansion program to create a more modern and capable fleet in response to naval treaties and the perceived threat from other naval powers.
Design and Description
The Kuma-class cruisers were designed for long-range reconnaissance missions and to serve as fleet flagships. Tama had a standard displacement of 5,500 tons and measured 162.1 meters in length, with a beam of 14.2 meters and a draft of 4.8 meters. The ship was powered by geared steam turbines driving four propellers, with boilers providing a top speed of 36 knots. Her main armament consisted of seven 140mm/50 3rd Year Type naval guns, and she was also equipped with two triple torpedo tube launchers, anti-aircraft guns, and depth charges for anti-submarine warfare.
Service History
Tama was laid down at the Kawasaki Shipbuilding Corporation in Kobe on February 16, 1920, launched on November 10, 1921, and commissioned into the IJN on January 29, 1923. Throughout the 1920s and 1930s, Tama primarily served on training and patrol missions in the Pacific, showing the flag and asserting Japanese presence.
With the outbreak of the Second Sino-Japanese War in 1937, Tama was involved in operations along the coast of China, providing naval gunfire support and enforcing blockades. As tensions escalated into the Pacific theater of World War II, Tama saw increased action.
During World War II, Tama participated in several significant operations, including the Aleutian Islands Campaign, where Japanese forces attempted to divert American attention from the Midway operation by invading the Aleutian Islands of Attu and Kiska. Tama's role was primarily as a troop transport and escort for the invasion forces.
In 1943, Tama was reassigned to the Northern Force and was involved in numerous operations and escort missions in the northern Pacific and the Aleutians. The cruiser faced harsh weather conditions and the constant threat of submarine attacks during these missions.
Tama's end came in October 1944, when she was torpedoed by the submarine USS Jallao (SS-368) while en route from the Kuril Islands to Paramushiro. The torpedo attack caused severe damage, and Tama sank with a significant loss of life.
Legacy
The loss of Tama was a part of the larger attrition of Japanese naval power in the Pacific. Her service history reflects the extensive use of light cruisers by the IJN for a variety of roles, from fleet reconnaissance and escort to direct combat operations. The Kuma-class cruisers, including Tama, demonstrated the versatility and capability of light cruisers in early 20th-century naval warfare but also their vulnerability in the face of evolving naval technology and tactics.
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD